Loading...
MedinCell Community
ENXTPA:MEDCL Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
Community Investing Ideas
Global Expansion And Extended Patents Will Unlock Future Opportunities
Key Takeaways Expansion of UZEDY and BEPO®-based programs, along with strong partnerships, underpin growth and reduce reliance on a single product. Extended patent protection and real-world value evidence support sustained pricing power and margin strength amid growing demand globally.
2users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
€24.47
2.9% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
69.78% p.a.
Profit Margin
51.4%
Future PE
16.71x
Share price in 2028
€24.02